Electra Therapeutics, Inc.
Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All ETRA news ›Retension Pharmaceuticals IPO priced at $12, raising $45 million
As seen on the 24/7 Wall St. homepage on October 9, 2026. Priced at $12, raising roughly $45 million Retension Pharmaceuticals priced at $12 a share, locking in about $45 million from 3.75 million shares with Leerink Partners and…
XORTX Moves to File Health Canada Trial Application for XRx-026 Gout Program
The latest update is out from XORTX Therapeutics Inc ( (XRTX) ). More about XORTX Therapeutics Inc Average Trading Volume: 201,993 Current Market Cap: $3.14M For detailed information about XRTX stock, go to TipRanks’ Stock Analysis page.
Eli Lilly-backed TRex Bio closes day flat after IPO
TRex Bio closes at $14 IPO price despite volatility in its trading debut. Read more here. - TRexBio(TRXB), which is backed by Eli Lilly (LLY), closed Friday, its first day of trading, at its IPO price, $14. - Shares opened at $13.50. They…
Eli Lilly-backed TRexBio prices $117M US IPO at $14 per share
(LLY:NYSE) Seeking Alpha - TRex Bio (TRXB) prices IPO at $14 per share, offering 8.33 million shares to the public, as the clinical-stage biotech company focuses on developing immunoregulatory medicines targeting tissue regulatory T-cell…
TRex Bio Leads 2 Drugmakers Pricing IPOs Totaling $162M
Law360 TRex Bio Leads 2 Drugmakers Pricing IPOs Totaling $162M By Jade Martinez-Pogue · October 9, 2026, 8:53 PM EDT Get instant access to the one-stop news source for business lawyers Email (NOTE: Free email domains not supported)…
City Therapeutics Seeks $184.7M in Nasdaq IPO
City has research tie ups with Bausch + Lomb Corp. for eye disorders and with Biogen Inc. for central nervous system diseases. John Maraganore, the founding CEO of Alnylam Pharmaceuticals Inc., co-founded City and serves as executive…
ADC Therapeutics Raises $86.6 Million And Restructures Debt To Extend Cash Runway Into 2029
ADC Therapeutics announced a comprehensive financial restructuring that includes an $86.6 million private placement, amendments to its HealthCare Royalty agreement, and a refinancing of its senior secured loan. The company said the…
IBRX Stock Jumps 6% Pre-Market On BCG Update In Saudi Arabia – Retail Says Share Price Is ‘Attractive’
Shares of ImmunityBio, Inc. (IBRX) climbed about 6% in premarket trading on Tuesday after the Saudi Food and Drug Authority (SFDA) encouraged the company to submit a regulatory filing for its recombinant Bacillus Calmette-Guérin (rBCG), a…
TRexBio, Retension raise $161.7M in IPOs; City, Iambic set proposed offering terms
The biotech IPO frenzy is very much alive this October spooky season, with TRexBio and Retension Pharmaceuticals set to begin trading Friday with offerings totaling $161.7 million. City Therapeutics and Iambic Therapeutics are lined up…
AVAX One Debuts on Nasdaq with $550M Capital Raise, Backed by Hivemind & 50+ Institutions
Home - Cryptocurrency News - AVAX One Debuts on Nasdaq with $550M Capital Raise, Backed by Hivemind & 50+ Institutions AgriFORCE Growing Systems has announced a major shift, rebranding as AVAX One and setting its sights on becoming the…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
tradingview.com10
-
briefs.co4
-
pulse2.com4
-
biospace.com3
-
defenseworld.net3
Measured across the 4Massachusetts news index. Headline tone is a simple word-based reading of the latest 118 headlines, not a forecast.